Clobetasol Propionate
Sponsors
Uniwersytet Medyczny W Lublinie, Centre Hospitalier Universitaire Amiens Picardie, Stiefel, a GSK Company, GlaxoSmithKline, Academic and Community Cancer Research United
Conditions
Alopecia AreataBullous PemphigoidBullous pemphigoidCataractCataracts InfantileColon AdenocarcinomaDermatitis, AtopicHand Dermatosis
Phase 1
A Study Assessing GW870086's Potential to Cause Skin Thinning
CompletedNCT01381445
Start: 2011-04-14End: 2011-07-07Updated: 2017-07-21
BAY1003803 Single and Multiple Dose Escalation, Safety, Tolerability and Pharmacokinetics Study
TerminatedNCT02936492
Start: 2016-10-24End: 2017-10-16Updated: 2017-11-08
BAY1003803 Formulation Comparison in Open Psoriasis Plaque Test
CompletedNCT02940002
Start: 2016-10-12End: 2017-03-17Updated: 2017-03-21
Phase 2
Lower or Standard Dose Regorafenib in Treating Patients With Refractory Metastatic Colorectal Cancer
CompletedNCT02368886
Start: 2015-03-27End: 2023-03-02Updated: 2025-06-18
Topical Betamethasone and Clobetasol in Orabase in Oral Lichen Planus
NCT03026478
Start: 2016-05-06End: 2018-06-30Target: 30Updated: 2018-03-14
Intra-oral Treatment of OLP With Rivelin®-CLO Patches
CompletedNCT03592342
Start: 2018-06-28End: 2019-12-20Updated: 2020-07-14
Efficacy of Topical Treatment With Clobetasol in Symptomatic Oral Lichen Planus.
Active, not recruitingNCT04364555
Start: 2020-05-18End: 2025-12-31Target: 90Updated: 2024-12-04
Phase 3
Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% for the Treatment of Inflammation and Pain Associated With Cataract Surgery (CLOSE-1)
CompletedNCT04246801
Start: 2020-06-10End: 2021-05-19Updated: 2022-12-22
Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% for the Treatment of Inflammation and Pain Associated With Cataract Surgery (CLOSE-2)
CompletedNCT04249076
Start: 2020-06-04End: 2021-04-14Updated: 2022-12-22
Rebamipide (Regular & Nanoparticulated) vs. Clobetasol in Management of Methotrexate-Induced Oral Ulceration in Rheumatoid Arthritis Patients
NCT04649697
Start: 2020-12-01End: 2023-12-30Target: 39Updated: 2023-09-21
Plasma Rich in Growth Factors (PRGF) for the Treatment of Lichen Sclerosus Atrophicus of the Vulva
WithdrawnNCT05364515
Start: 2021-12-23End: 2024-02-15Updated: 2025-02-27
Clobetasol Propionate Ophthalmic Nanoemulsion, 0.05% in the Treatment of Inflammation After Cataract Surgery in Pediatric Population
RecruitingNCT05724446
Start: 2022-12-12End: 2025-12-31Target: 60Updated: 2024-09-27
Randomised phase III, partly blinded study comparing the efficacy and safety of clobetasol, mometasone and tacrolimus in the treatment of lichen sclerosus of the vulva in a paediatric population.
Not yet recruitingCTIS2024-514003-33-00
Target: 93Updated: 2025-08-29
Phase 4
Study to Evaluate Safety, Efficacy and Tolerability of Clobetasol Propionate for Chronic Hand Dermatitis
CompletedNCT00828464
Start: 2008-10-31End: 2009-01-31Updated: 2012-10-03
Topical 5% Minoxidil and Potent Topical Corticosteroid Versus Intralesional Corticosteroid in the Treatment of Alopecia Areata
CompletedNCT03535233
Start: 2016-03-31End: 2017-09-30Updated: 2018-05-24
Influence of Dermocorticoids on Bone Mineral Density in Patients With Bullous Pemphigoid
NCT03926377
Start: 2019-04-01End: 2024-04-30Target: 50Updated: 2023-04-13
DERMOS study : Influence of dermocorticoids on bone mineral density in patients with bullous pemphigoid.
Not yet recruitingCTIS2024-515676-12-00
Target: 50Updated: 2024-07-31